Allergy Shots and Pregnancy: Continuation vs. Initiation — The Critical Rule
Per Cox 2011 PP3, continuation of maintenance allergy shots during pregnancy is permissible — but initiation of allergy shots during pregnancy is NOT permissible because the build-up phase carries unacceptable systemic-reaction risk. Maternal anaphylaxis during build-up can cause fetal hypoxia. Metzger 1978 (n=121 pregnancies) and Shaikh 1993 (n=109 pregnancies) both document safe SCIT continuation outcomes. This is the most critical clinical distinction on this page.
5 peer-reviewed sources
SCIT continuation during pregnancy at the current maintenance dose is generally safe per Cox 2011 PP3, Metzger 1978, and Shaikh 1993. SCIT initiation or build-up during pregnancy is contraindicated due to anaphylaxis risk and potential fetal hypoxia.
The essentials
Per Cox 2011 PP3, continuation of maintenance allergy shots during pregnancy is permissible — but initiation of allergy shots during pregnancy is NOT permissible, because the build-up phase carries unacceptable systemic-reaction risk. This continuation-versus-initiation distinction is the entire clinical content of this page; the question is never simply 'are allergy shots safe in pregnancy?'
The rationale is mechanistic: the build-up phase is when systemic allergic reactions cluster, because progressively higher doses provoke immune responses at each step. If anaphylaxis occurs during build-up in a pregnant patient, maternal hypotension and hypoxia translate directly to fetal hypoxia — a risk that does not exist at the stable maintenance dose when the immune system has already adapted to the allergen concentration. Cox 2011 PP3 is unambiguous: maintenance continuation is permissible; build-up initiation is not.
For women planning pregnancy who are evaluating whether to start allergen immunotherapy now versus wait until postpartum, Curex's at-home IgE testing with board-certified allergist review identifies the sensitization profile and helps establish a timeline — initiation before conception is permissible; initiation during pregnancy is not.
The observational evidence base for safe SCIT continuation is documented across two foundational retrospective cohorts. Metzger WJ, Turner E, Patterson R (JACI 1978;61:268–272) analyzed 90 atopic women across 121 pregnancies undergoing SCIT: no significant increase in prematurity, hypertension/proteinuria, or congenital malformations versus controls; none of 7 generalized reactions resulted in abnormal births. Shaikh WA (Clin Exp Allergy 1993;23:857–860; DOI 10.1111/j.1365-2222.1993.tb00264.x) analyzed 81 atopic women across 109 pregnancies (102 receiving SCIT before conception): prematurity and hypertension/proteinuria were actually lower in the continuation group; none of 3 systemic reactions caused birth complications. Conclusion from Shaikh 1993: 'immunotherapy for allergic diseases is safe in pregnancy.'
Practical continuation-management protocols per Cox 2011 PP3: many clinicians hold the maintenance dose at the current level rather than advancing during pregnancy; some slightly reduce it. The 30-minute post-injection observation period remains mandatory throughout pregnancy. Epinephrine premedication is NOT recommended for routine SCIT continuation. Live-attenuated vaccines (which would not normally be co-administered in pregnancy regardless) remain contraindicated. Postpartum re-initiation: if SCIT was discontinued during pregnancy, re-initiation is permissible after delivery.
The pregnancy-plus-asthma balance: uncontrolled maternal asthma is itself a fetal-hypoxia risk per Cox 2011 PP3. For a pregnant patient already on maintenance SCIT who has asthma under good control, maintaining SCIT-driven asthma control is often the lower-risk choice than discontinuing.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youSide effects — what to watch for
Systemic reaction risk during SCIT in pregnant patients is greatest during the build-up phase — the reason initiation during pregnancy is contraindicated. At stable maintenance doses, the systemic reaction rate per injection is approximately 0.1–0.2% per Epstein TG et al. (Ann Allergy Asthma Immunol 2013/2014). Maternal anaphylaxis carries additional fetal risk via hypoxia, making the 30-minute observation period especially important throughout pregnancy.
Frequently asked questions
Can I continue allergy shots while pregnant?
Yes, if you were already at the maintenance dose before conception. The AAAAI/ACAAI Practice Parameter Third Update (Cox et al., JACI 2011) permits continuation of maintenance SCIT during pregnancy. The foundational safety evidence comes from Metzger WJ et al. (JACI 1978;61:268–272) — 90 atopic women across 121 pregnancies with no significant increase in prematurity, hypertension/proteinuria, or congenital malformations compared to controls — and Shaikh WA (Clin Exp Allergy 1993;23:857–860) — 81 atopic women across 109 pregnancies with prematurity rates actually lower in the continuation group. Clinicians typically hold the dose at the current maintenance level rather than advancing, and the mandatory 30-minute observation period continues at every injection.
Can I start allergy shots during pregnancy?
No. Initiating SCIT during pregnancy is contraindicated per Cox 2011 PP3. The build-up phase carries the highest systemic-reaction risk because progressively higher doses provoke the immune system at each step. If anaphylaxis occurs during build-up, maternal hypotension and hypoxia directly threaten fetal oxygenation. The contraindication is specific to initiation and build-up — patients already on stable maintenance doses before conception may continue. Women who want to start SCIT should begin before conception if possible, or wait until the postpartum period.
What if I discover I'm pregnant while in the build-up phase of allergy shots?
If you discover pregnancy while in the build-up phase of SCIT, you should contact your allergist immediately. Per Cox 2011 PP3, the build-up phase (where doses are progressively increasing) carries the highest systemic-reaction risk and is effectively contraindicated during pregnancy. Most allergists will advise stopping the build-up advancement and either holding at the current dose or discontinuing temporarily, with re-initiation planned for postpartum. Continuing to advance doses during the build-up phase while pregnant is not recommended because of the fetal hypoxia risk associated with maternal anaphylaxis.
Is it safe to get allergy shots in the first trimester?
For patients already on stable maintenance SCIT, continuation during the first trimester is generally safe per Cox 2011 PP3, Metzger 1978, and Shaikh 1993. Clinical practice per Cox 2011 PP3 is to continue at the current maintenance dose without advancing, and some clinicians slightly reduce the dose. First-trimester patients who discover pregnancy mid-build-up should contact their allergist immediately, as advancement during the build-up phase is contraindicated regardless of trimester. The mandatory 30-minute observation period remains in force throughout the first trimester.
What are the risks of allergy shots during pregnancy?
For patients at stable maintenance doses, the primary risk is systemic reaction (approximately 0.1–0.2% per injection per Epstein 2014 AAAAI surveillance) — which, in pregnant patients, carries the additional consequence of potential fetal hypoxia if maternal hypotension occurs. This is why the risk is considered acceptable at maintenance (where reactions are rare) but not acceptable during build-up (where reactions cluster with each advancing dose). Metzger 1978 documented 7 generalized reactions across 121 pregnancies with no adverse fetal outcomes, suggesting that even when reactions occur at maintenance, careful management prevents fetal harm — whether that management occurs in a clinic or, for at-home SCIT maintenance patients, through immediate epinephrine use, calling 911, and notifying the care team. The key is ensuring the 30-minute alert window is observed and that a prescribed epinephrine auto-injector is within reach at every injection throughout pregnancy.
Can I restart allergy shots after giving birth?
Yes. Postpartum re-initiation of SCIT is permissible, and the contraindication on initiation lifts after delivery. If SCIT was discontinued during pregnancy, re-initiation typically does not resume from the last pre-pregnancy maintenance dose — the allergist will usually restart from a more dilute vial because immune tolerance may have partially decayed during the gap. If SCIT was continued throughout pregnancy at maintenance dose, the patient can typically resume their regular maintenance schedule postpartum without a dose rollback, depending on how much time elapsed since the last injection. Breastfeeding is generally compatible with SCIT continuation.
Does getting allergy shots before pregnancy affect the fetus later?
No harmful fetal effects from allergen extract SCIT have been documented in the published literature. Both Metzger 1978 and Shaikh 1993 found no significant differences in prematurity rates, hypertension/proteinuria, or congenital malformations between women on SCIT versus controls. The extract proteins themselves are FDA-licensed allergen materials — not pharmacological agents — and the doses used in SCIT are calibrated to provoke an immune response, not to deliver pharmacologically active compounds across the placenta. There is no evidence that completing a SCIT course before pregnancy affects fetal development.
Related Articles
Allergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreAllergy Shots for Kids: PAT Study & Age Guide | Curex
Allergy shots from age 5. PAT study: 3 yrs SCIT halves asthma risk (OR 4.6). At-home SCIT via Curex for eligible pediatric families.
Read moreAllergy Shots in Pregnancy: Trimester Guide | Curex
Allergy shots in pregnancy: continue maintenance, never initiate. Trimester guide per Cox 2011 PP3, Metzger 1978, and Shaikh 1993 safety data.
Read moreAllergy Desensitization: Which Treatment Type? | Curex
Allergy desensitization is active allergen-specific immunotherapy (SCIT or SLIT). Differs from passive immunotherapy and pharmacotherapy in mechanism.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.